Description
Test whether chromatin accessibility changes are upstream drivers of neurodegeneration rather than downstream effects. If true, targeting chromatin regulators should alter disease course.
Bounty funding curve
No bounty top-ups yet — the pot still sits at its initial size.
Cumulative-token contributions to this bounty will plot here as funders top up the pot.
Submissions 0
No submissions yet.